AnaptysBio
ANAB
ANAB
131 hedge funds and large institutions have $733M invested in AnaptysBio in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 52 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 52
Holders
131
Holding in Top 10
2
Calls
$362K
Puts
–
Top Buyers
| 1 | +$26.2M | |
| 2 | +$13.8M | |
| 3 | +$7.42M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.54M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.88M |
Top Sellers
| 1 | -$31.3M | |
| 2 | -$3.53M | |
| 3 | -$2.7M | |
| 4 |
Goldman Sachs
New York
|
-$2.16M |
| 5 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$2.04M |